Table 2 Clinical, Imaging Characteristics, Treatment and Outcomes of Patients with AS + Cardiac Amyloidosis
From: Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 | Patient 8 | Patient 9 | |
|---|---|---|---|---|---|---|---|---|---|
ECG Rhythm | AFib | AFib | AFib | AFib | NSR | NSR | S. Tach | AFib | AFib |
Low Voltage Criteria | No | No | No | No | No | No | No | No | No |
Echocardiographic findings | |||||||||
IVS/IL Thickness (cm) | 2.0/1.9 | 1.7/1.5 | 1.7/1.4 | 1.9/1.5 | 1.8/1.5 | 1.9/1.5 | 1.6/1.6 | 2.1/1.9 | 1.6/1.6 |
Aortic Valve Area (cm2) | 0.3 | 0.7 | 0.4 | 0.9 | 0.6 | 0.8 | 0.6 | 1.1 | 0.5 |
Mean AV Gradient (mmHg) | 18 | 33 | 33 | 13 | 30 | 47 | 37 | 12 | 50 |
Stroke Volume Index (ml/m2) | 16 | 32 | 27 | 22 | 28 | 35 | 14 | 21 | 37 |
CMR Findings | |||||||||
LV Ejection Fraction (%) | 23 | 45 | 35 | 53 | 35 | 67 | 18 | 49 | 51 |
LV End-Diastolic Vol Index (ml/m2) | 104 | 64 | 93 | 60 | 94 | 47 | 91 | 88 | 101 |
LV Mass Index (g/m2) | 101 | 103 | 97 | 113 | 108 | 73 | 84 | 139 | 128 |
Native T1 (msec) | 1127 | N/A | 1115 | 1141 | 1097 | 1091 | 1081 | 1225 | N/A |
ECV (%) | 70 | N/A | 40 | 33 | 28 | 35 | N/A | 46 | N/A |
Treatment and outcomes | |||||||||
Aortic Valve Replacement | No | No | TAVR | No | TAVR | No | No | TAVR | TAVR |
Status | Dead | Dead | Dead | Alive | Alive | Alive | Dead | Alive | Dead |
Survival after CMR (months) | 1 | 2 | 3 | 6 | 8 | 8 | 3 | 5 | 2 |